Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells

Annekathrin Reinhardt1, Hongyu Liu2, Yunxia Ma3

  • 1Department of Neuropathology, Institute for Pathology, University of Heidelberg, Heidelberg, Germany.

Abstract

Insights

Combining tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) with all-trans retinoic acid (ATRA) synergistically inhibits breast cancer cell viability. This novel combination demonstrates tumor cell-selective cytostatic and cytotoxic effects, offering a promising alternative treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Breast cancer treatment faces challenges with pharmacoresistance.
  • Exploring novel therapeutic strategies is crucial for clinical relevance.
  • This study investigates the combined effects of TRAIL and ATRA on breast cancer cells.

Purpose of the Study:

  • To evaluate the tumor cell-inhibiting effects of combined TRAIL and ATRA.
  • To assess the selectivity of this combination therapy against breast cancer cells.
  • To elucidate the mechanisms underlying the synergistic effects.

Main Methods:

  • Utilized multiple breast cancer cell lines and a normal mammary epithelial cell line.
  • Assessed cell viability (MTT assay) and colony formation (clonogenic assay).
  • Analyzed cell death (FACS, TUNEL, ELISA), protein expression (Western blot), and receptor expression (FACS).

Main Results:

  • TRAIL and ATRA demonstrated synergistic inhibition of breast cancer cell viability.
  • Mechanisms included cytostatic and cytotoxic effects, DNA fragmentation, and enhanced caspase activity.
  • Up-regulation of TRAIL receptor and down-regulation of cyclin D1 were observed.
  • Normal mammary epithelial cells showed only slight susceptibility.

Conclusions:

  • The combination of TRAIL and ATRA exhibits potent cytostatic and cytotoxic effects.
  • These effects are selective for tumor cells, sparing normal mammary epithelial cells.
  • This combination represents a promising therapeutic approach for breast cancer treatment.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.6K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K